Slone Partners Places VP of North American Capital Sales at HTG Molecular Diagnostics

Share Article

Suzanne Hill, life sciences executive, to lead the North American sales team in the commercialization of the HTG EdgeSeq system for HTG Molecular.

Ms. Hill's genomics sales leadership, especially her seven years at Illumina during their initial commercial ramp up phase, will be extremely helpful as we accelerate the commercialization of HTG's instrument platform.

National recruitment firm Slone Partners is pleased to announce the placement of Suzanne Hill, a life sciences executive with extensive sequencing and genomics experience, as Vice President of North American Capital Sales at HTG Molecular.

In this position, Ms. Hill will be responsible for leading the sales team in the commercialization of the HTG EdgeSeq system and associated reagents in North America.

Headquartered in Tucson, Arizona, HTG's mission is to empower precision medicine at the local level. In 2013, the company commercialized its HTG Edge instrument platform and a portfolio of RNA assays that leverage HTG's proprietary nuclease protection chemistry. HTG's product offerings have since expanded to include its HTG EdgeSeq product line, which automates sample and targeted library preparation for next-generation sequencing.

"We are delighted to be able to recruit someone of Suzanne's background and experience," stated TJ Johnson, Chief Executive Officer and President of HTG. "Ms. Hill's genomics sales leadership, especially her seven years at Illumina during their initial commercial ramp up phase, will be extremely helpful as we accelerate the commercialization of HTG's instrument platform."

Tara Kochis-Stach, President of Slone Partners, said, “We partnered with HTG to identify and deliver a leader who has a proven track record of leading a commercialization team in the next generation sequencing space, and Suzanne exemplifies that role. HTG’s EdgeSeq technology has a promising future, and we are privileged to support their leadership team as the organization grows.”

Prior to joining HTG, Ms. Hill served as Director of Sales at Silicon Biosystems in San Diego, CA. Earlier in her career, she held a number of commercial positions of increasing responsibility at Illumina, Inc. Prior to her seven years at Illumina, Ms. Hill served as the Director of Sales for North America at CryoXtract, the Mid Atlantic Regional Sales Manager at Leica, and Regional and Global Account Executive at Perkin Elmer and Roche.

Ms. Hill earned a B.S. in biology and plant genetics from the Penn State University.

About Slone Partners
Founded in 2000, Slone Partners is a premier executive search firm that specializes in recruitment for the diagnostics, life science tools, clinical trials, contract research, healthcare information technology, and laboratory testing industries. Slone Partners has offices in Boston, New York, Washington, D.C., and San Francisco. For additional information, visit: http://www.slonepartners.com.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Valerie Lavoie - Marketing Manager
@SlonePartners
Follow >
Slone Partners
Like >
Slone Partners

Follow us on
Visit website